TRANSFORMED EXTRANODAL MALT LYMPHOMA
Clinical trials for TRANSFORMED EXTRANODAL MALT LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSFORMED EXTRANODAL MALT LYMPHOMA trials appear
Sign up with your email to follow new studies for TRANSFORMED EXTRANODAL MALT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy hopes to tackle tough lymphoma
Disease control OngoingThis early-phase trial is testing a new drug called venetoclax combined with standard chemotherapy drugs for people with aggressive B-cell lymphoma that has come back or stopped responding to treatment. The main goal is to find the highest safe dose of the new combination. About …
Matched conditions: TRANSFORMED EXTRANODAL MALT LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New cocktail of drugs tested for Tough-to-Treat lymphoma
Disease control OngoingThis phase 2 trial is testing several new drug combinations for people with aggressive B-cell lymphoma that has come back or not responded to standard therapy. About 129 participants will receive one of several experimental combinations, including drugs like ibrutinib and selinex…
Matched conditions: TRANSFORMED EXTRANODAL MALT LYMPHOMA
Phase: PHASE2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC